Poster Presentation – A Phase 2 Clinical Trial of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in an Allergen Chamber Model of Allergic Conjunctivitis (American Academy of Ophthalmology 2020 Annual Meeting)
Poster Presentation – A Phase 2 Clinical Trial of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in an Allergen Chamber Model of Allergic Conjunctivitis (American Academy of Ophthalmology 2020 Annual Meeting)
November 2020